Back to all papers

Integrating Intratumoral and Peritumoral Features via a Cross-Attention Transformer on Super-resolution MRI for Glioblastoma Survival Risk Stratification: A Multicenter Study.

November 18, 2026pubmed logopapers

Authors

Zhao E,Liu X,Zheng X,Fan T,Wang Y,Zhang T,Gao X,Shi Y,Yang C,Liu J

Affiliations (6)

  • Department of Radiology, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, Tianjin 300140, China (E.Z., X.Z., T.F., Y.W., X.G., J.L.).
  • Department of Radiology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin 300121, China (X.L., J.L.).
  • Tianjin Fourth Central Hospital, Tianjin University, Tianjin 300072, China (T.Z., J.L.).
  • Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China (Y.S.).
  • Department of Radiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China (C.Y.).
  • Department of Radiology, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, Tianjin 300140, China (E.Z., X.Z., T.F., Y.W., X.G., J.L.); Department of Radiology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin 300121, China (X.L., J.L.); Tianjin Fourth Central Hospital, Tianjin University, Tianjin 300072, China (T.Z., J.L.). Electronic address: [email protected].

Abstract

To develop and validate a Cross-Region Transformer using super-resolution (SR) magnetic resonance imaging (MRI) to integrate intratumoral and peritumoral features for overall survival (OS) prediction in glioblastoma. This multicenter study included 362 patients (training, n = 228; internal test, n = 57; external validation, n = 77). Preoperative contrast-enhanced T1-weighted and T2-weighted MRI underwent generative adversarial network-based SR reconstruction. Intratumoral and 10-mm peritumoral features were extracted using 2.5D convolutional neural networks and fused by asymmetric cross-attention to generate a deep learning-based risk score (DLRS), which was combined with independent clinical factors. Performance was evaluated using C-index, time-dependent receiver operating characteristic analysis, calibration, decision curve analysis, Gradient-weighted Class Activation Mapping, and SHapley Additive exPlanations. The Cross-Region Transformer achieved C-indices of 0.787 (95% confidence interval [CI], 0.734-0.840), 0.711 (95% CI, 0.593-0.829), and 0.726 (95% CI, 0.627-0.826) in the training, internal test, and external validation cohorts, respectively, with numerically higher discrimination than single-region and feature-concatenation models. The combined clinical-DLRS model, incorporating the Stupp regimen, number of lesions, Ki-67 index, and DLRS, achieved corresponding C-indices of 0.836 (95% CI, 0.788-0.884), 0.742 (95% CI, 0.628-0.855), and 0.754 (95% CI, 0.658-0.850). The DLRS significantly stratified OS in external validation (median, 7.5 vs 23.5 months; P < 0.001). Interpretability analyses highlighted enhancing margins within the necrotic core and the intratumoral-peritumoral interface. The Cross-Region Transformer integrates complementary intratumoral and peritumoral representations from SR MRI. The resulting interpretable DLRS supports noninvasive survival prediction and risk stratification in glioblastoma.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.